title: The association of factor V Leiden with various clinical patterns of venous thromboembolism-the factor V Leiden paradox.
abstract: BACKGROUND
  Factor V Leiden (FVL) supposedly carries relatively higher risk of deep vein thrombosis (DVT), compared to the risk of pulmonary embolism (PE).
  
  
  OBJECTIVE
  To prove this paradox in a group of patients with various clinical presentation of venous thromboembolism (VTE).
  
  
  METHODS
  We retrospectively evaluated clinical pattern of VTE in patients who had been referred to vascular clinic shortly after an acute VTE event. In FVL positive and FVL negative groups we compared the prevalence of isolated symptomatic DVT (proximal or distal) and symptomatic PE with/without DVT, and, moreover, asymptomatic DVT or PE.
  
  
  RESULTS
  Of 575 patients (mean age 57 years, 50.1% women), 120 were FVL positive and those had significantly higher prevalence of isolated symptomatic DVT, compared to symptomatic PE with/without DVT. Proximal DVT location was significantly more frequent in FVL carriers. The prevalence of asymptomatic PE did not differ between the two groups. The rate of asymptomatic DVT tended to be higher in FVL negative group. In a multivariate analysis, we confirmed FVL to be positively associated with isolated DVT presentation (odds ratio OR 1.757; 95% confidence interval (CI) 1.148-2.690). On the contrary, increasing age and unprovoked nature of VTE event carried a higher risk of symptomatic PE.
  
  
  CONCLUSIONS
  We confirmed FVL to be significantly associated with isolated symptomatic DVT despite higher prevalence of proximal DVT in FVL carriers. The fact of relatively lower risk of PE in FVL positive patients might have clinical implication. However, mechanisms of FVL paradox remain to be elucidated.
authors.affiliation: From the 2nd Department of Internal Medicine and Institute of Medical Genetics, University Hospital, Charles University, Dr. E. Benese 13, 305 99 Pilsen, Czech Republic hirmerova@fnplzen.cz.
authors.forename: J
authors.initials: J
authors.lastname: Hirmerova
authors.affiliation: From the 2nd Department of Internal Medicine and Institute of Medical Genetics, University Hospital, Charles University, Dr. E. Benese 13, 305 99 Pilsen, Czech Republic.
authors.forename: J
authors.initials: J
authors.lastname: Seidlerova
authors.affiliation: From the 2nd Department of Internal Medicine and Institute of Medical Genetics, University Hospital, Charles University, Dr. E. Benese 13, 305 99 Pilsen, Czech Republic.
authors.forename: I
authors.initials: I
authors.lastname: Subrt
mesh_terms: D000328:Adult; D000368:Aged; D058070:Asymptomatic Diseases / Q000453:epidemiology; D001777:Blood Coagulation / Q000235:genetics; D005165:Factor V / Q000235:genetics*; D005260:Female; D006580:Genetic Carrier Screening; D006801:Humans; D007494:Ireland; D008297:Male; D008875:Middle Aged; D017354:Point Mutation; D015995:Prevalence; D011655:Pulmonary Embolism / Q000453:epidemiology / Q000235:genetics / Q000503:physiopathology; D012189:Retrospective Studies; D020246:Venous Thrombosis / Q000453:epidemiology / Q000235:genetics / Q000503:physiopathology
chemical_list: C095381:factor V Leiden; D005165:Factor V